3-phosphoinositide-dependent protein kinase-1 (PDK1) phosphorylates and activates many kinases belonging to the AGC subfamily. PDK1 possesses a C-terminal pleckstrin homology (PH) domain that interacts with PtdIns(3,4,5)P 3 / PtdIns(3,4)P 2 and with lower affinity to PtdIns(4,5)P 2 . We describe the crystal structure of the PDK1 PH domain, in the absence and presence of PtdIns(3,4,5)P 3 and Ins(1,3,4,5)P 4 . The structures reveal a 'budded' PH domain fold, possessing an N-terminal extension forming an integral part of the overall fold, and display an unusually spacious ligand-binding site. Mutagenesis and lipid-binding studies were used to define the contribution of residues involved in phosphoinositide binding. Using a novel quantitative binding assay, we found that Ins(1,3,4,5,6)P 5 and InsP 6 , which are present at micromolar levels in the cytosol, interact with full-length PDK1 with nanomolar affinities. Utilising the isolated PDK1 PH domain, which has reduced affinity for Ins (1, 3,4,5,6)P 5 /InsP 6 , we perform localisation studies that suggest that these inositol phosphates serve to anchor a portion of cellular PDK1 in the cytosol, where it could activate its substrates such as p70 S6-kinase and p90 ribosomal S6 kinase that do not interact with phosphoinositides.
Introduction
3-phosphoinositide-dependent protein kinase-1 (PDK1) plays an important role in insulin and growth factor signalling cascades (Toker and Newton, 2000; Mora et al, 2004) . It is known to phosphorylate and activate at least 24 protein kinases that belong to the AGC (cAMP-dependent, cGMPdependent, protein kinase C (PKC)) family of protein kinases. These comprise isoforms of protein kinase B (PKB, also known as Akt), p70 ribosomal S6-kinase (S6K), serum and glucocorticoid responsive kinase (SGK), p90 ribosomal S6 kinase (RSK) and PKC. PDK1 activates these enzymes by phosphorylating a Ser/Thr residue in their activation loop. PDK1 is a 556 amino-acid protein comprising an N-terminal Ser/Thr kinase catalytic domain (residues 71-359) and a C-terminal pleckstrin homology (PH) domain (residues 459-550) (Alessi et al, 1997; Stephens et al, 1998) . The latter binds with high affinity to the second messenger phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) Currie et al, 1999) , generated through insulinand growth factor-induced activation of PI 3-kinase (Vanhaesebroeck et al, 2001) .
Much research has shown that insulin and growth factors control PDK1 by regulating its interaction with substrates, rather than by directly activating PDK1. PKB, in contrast to other PDK1 substrates, possesses a PtdIns(3,4,5)P 3 -binding PH domain. The mutual ability of PKB and PDK1 to interact with PtdIns(3,4,5)P 3 via their PH domains is likely to play a crucial role in regulating PKB activation Currie et al, 1999; Filippa et al, 2000) . Consistent with this notion, PKB was not substantially activated in a knockin ES cell line expressing an active form of PDK1 that cannot interact with PtdIns(3,4,5)P 3 (McManus et al, 2004) . Recent structural and cellular studies have also indicated that binding of PKB to PtdIns(3,4,5)P 3 induces a major conformational change (Mora et al, 2004) that is likely to be required for PKB activation by PDK1 (Alessi et al, 1997; Stokoe et al, 1997) . Importantly, binding of PtdIns(3,4,5)P 3 to the PDK1 PH domain does not directly affect activity of the PDK1 kinase domain, but stimulates PKB activation by inducing the colocalisation of PKB and PDK1 Currie et al, 1999) .
The other substrates that PDK1 activates, such as S6K, RSK and SGK, are phosphorylated by PDK1 in the cytosol, rather than at the plasma membrane. Moreover, these substrates do not possess PH domains or interact with phosphoinositides. Extracellular agonists regulate activation of S6K, RSK and SGK through PDK1, by inducing the phosphorylation of these enzymes at a conserved C-terminal (noncatalytic) hydrophobic motif, which creates a high-affinity docking site for interaction with a pocket located on the kinase domain of PDK1 (reviewed in Mora et al, 2004) . This has recently been supported by a knockin cell line in which the PDK1 hydrophobic motif docking site is disrupted (Collins et al, 2003) .
The PDK1 PH domain sequence is unusual compared to other PH domains and several computer algorithms, such as the Simple Modular Architecture Research Tool or PROSITE, fail to classify it as a PH domain. However, lipid-binding studies have firmly established that PDK1 binds PtdIns(3,4,5)P 3 through a C-terminal domain, and truncation or mutation of several conserved residues found in this domain abolishes PtdIns(3,4,5)P 3 binding Currie et al, 1999) . In addition to binding PtdIns(3,4,5)P 3 , PDK1 also binds with similar affinity to PtdIns(3,4)P 2 , a potential signalling lipid generated through the dephosphorylation of PtdIns(3,4,5)P 3 by the SHIP 5-phosphatase Currie et al, 1999) . Surface plasmon resonance-based lipid-binding assays revealed that PDK1 also interacts with PtdIns(4,5)P 2 , the substrate for PI 3-kinase, albeit with a 15-fold lower affinity compared to PtdIns(3,4,5)P 3 (Currie et al, 1999) . This weaker affinity for PtdIns(4,5)P 2 , may be significant as the basal cellular levels of this phospholipid are 50-200-fold higher than those of PtdIns(3,4,5)P 3 /PtdIns(3,4)P 2 in insulin-stimulated cells (Batty and Downes, 1996) . Consistent with this notion, quantitative electron microscopy localisation studies revealed that in unstimulated cells B10% of the cellular pool of PDK1 is associated with the plasma membrane in a manner dependent on an intact PH domain, which could be mediated through the ability of PDK1 to bind PtdIns(4,5)P 2 (Currie et al, 1999) . Whether insulin or growth factor stimulation induces further localisation of PDK1 at the plasma membrane is controversial Currie et al, 1999) . Nevertheless, a significant pool of PDK1 is required in the cytoplasm to activate its other non-lipid-binding substrates such as S6K, RSK and SGK. The mechanism by which PDK1 is anchored in the cytoplasm is not known. Here we define the molecular basis by which PDK1 interacts with its phosphoinositide ligands and show that PDK1 may be anchored in the cell cytosol through its interaction with D6-phosphorylated inositol phosphates.
Results and discussion

Structure determination of PDK1 PH domain
Constructs containing the predicted PH domain of PDK1 designed on the basis of sequence alignments with previously crystallised PH domains produced insoluble protein. To identify the boundaries of a soluble fragment of PDK1 containing the PH domain, a limited proteolysis approach was performed (described in Komander et al, 2004) , resulting in a proteolytically stable fragment of PDK1 comprising residues 408-556. We cloned and expressed in Escherichia coli a fragment of PDK1 encompassing residues 409-556, which showed good stability after purification and was readily crystallisable . The protein crystals, grown in the presence or absence of phosphoinositides, diffracted to below 1.50 Å on a rotating anode generator. The single cysteine in the sequence (Cys536) was exploited to obtain experimental phases, by derivatisation with AuCN. The structure of the PDK1 PH domain in complex with Ins(1,3,4,5)P 4 was solved by a two-wavelength MAD experiment (Table I ). The resulting map allowed building of residues 409-549, and showed well-defined electron density for Ins (1, 3, 4, 5 )P 4 ( Figure 1A ).
Overall structure of the 'budded' PDK1 PH domain
The structure of the PDK1 PH domain reveals a structural variation of a standard PH domain fold , with an additional 'bud' at the N-terminus (Figures 1B-D) . Residues 456-530 fold into two, almost orthogonal, b sheets, one consisting of four (b1-b4) and one of three strands (b5-b7), constituting a barrel-like structure ( Figures 1B-D) . On one side, the barrel is blocked by a C-terminal a helix (residues 531-549, Figures 1B and C) . The other side of the barrel consists of three loops (termed variable loop (VL) 1-3 (Ferguson et al, 1994) ), forming a bowl-like structure which is lined by positively charged residues, constituting the phosphoinositide-binding site. N-terminal to the observed standard PH domain fold, the PDK1 PH domain possesses an extension, here referred to as the 'bud'. This consists of two additional b strands, which extend the b1-b4 sheet in an antiparallel fashion, and an additional a helix, which packs against the newly formed sixstranded b sheet (Figures 1B and D) . The bud packs against the b1-b4 sheets of the PH domain, through several hydrophobic contacts ( Figure 1D ), but also through b-sheet hydrogen bonds between strands b2 0 and b1. Overall, the bud of the PDK1 PH domain buries more than 30% of the surface of the standard PH domain fold (567 Å 2 of 1749 Å 2 ), and a hydrophobic core is created between the a1 0 helix and residues on one face of the six-stranded b sheet ( Figure 1D ). Residues Ile416, Phe424, Leu426, Leu456, Ile457, Met460, Leu477, Tyr485, Val487 and Leu494 from the six-stranded b sheet interact with residues Ile412, Phe430, Leu438, Leu439, Trp448, Phe451, Val452 and Leu456 from the a1 0 helix and surrounding loops ( Figure 1D ). The presence of this additional hydrophobic core, which lies outside the standard PH domain fold, suggests that the bud is an integral part of the overall fold. This could explain the insolubility of protein obtained from initial constructs which covered the standard PH domain only (residue 458-556) . A bud-like extension of a PH domain fold as observed in PDK1 has not been described to date in any other crystallised PH domain containing protein. Although interactions of PH domains with other proteins or protein domains have been described in structures of Gbg binding to the GRK2 PH domain (Lodowski et al, 2003) , myotubularin-related protein phosphatase MTMR2 (Begley et al, 2003) , or the Rac1-Tiam1-like complexes (Worthylake et al, 2000) , none of these show the antiparallel b-sheet extension observed in the PDK1 PH domain and, therefore, do not resemble the bud on PDK1.
Interactions with the PtdIns(3,4,5)P 3 head group, Ins(1,3,4,5)P 4 The structure of the PDK1 PH domain was determined from a crystal that was grown in the presence of Ins(1,3,4,5)P 4 , and well-defined ligand density could be observed in the experimental maps ( Figure 1A , Table I ). The PDK1 PH domain binds Ins (1, 3, 4, 5 )P 4 in a location equivalent to that described for other PH domains (Baraldi et al, 1999; Ferguson et al, 2000; Lietzke et al, 2000; Thomas et al, 2002) , that is, within a shallow but positively charged pocket formed by VL1-3, at the open end of the b barrel ( Figure 1 ). The phosphoinositidebinding site is lined by positively charged residues that contact the phosphates of Ins (1,3,4,5)P 4 , and a total of 11 hydrogen bonds are possible between the PDK1 PH domain and Ins (1,3,4,5)P 4 (Figure 2A ). Arg472 contacts the phosphate at the D1 position (D1-phosphate) with two hydrogen bonds. The D3-phosphate is contacted by Arg474 (two hydrogen bonds) and Lys465. Lys495 is in close proximity (4.4 Å ) to the D3-phosphate. The D4-phosphate forms up to four hydrogen bonds to Lys465, Tyr486, and Arg521. Finally, the D5-phosphate makes one hydrogen bond to Lys467 (Figures 2A and 4A ). Neither the D2-nor the D6-hydroxy groups show any direct hydrogen bonds to the protein (Figure 2A) . Figure 2 shows a comparison of the structures of the PDK1, DAPP1 and PKBa (Thomas et al, 2002) PH domains in complex with Ins(1,3,4,5)P 4 . DAPP1 binds Ins(1,3,4,5)P 4 in a similar fashion to GRP1 Lietzke et al, 2000) and Btk (Baraldi et al, 1999) . The orientation of Ins (1, 3, 4, 5 )P 4 in PDK1 is identical to that found in DAPP1/Btk/GRP1 (Figure 2A and B), while in PKBa the Ins (1, 3, 4, 5 )P 4 molecule is rotated by 601 ( Figure 2C ) (Thomas et al, 2001) . However, in all PH domain Ins(1,3,4,5)P 4 complex structures described to date, Ins (1, 3, 4, 5 )P 4 interacts with both protein side chains as well as the backbone, whereas in PDK1 Ins (1, 3, 4, 5 )P 4 interacts with protein side chains only. This results in a significantly reduced number of protein-ligand hydrogen bonds in the PDK1 PH domain Ins (1, 3, 4, 5 )P 4 complex (a total of 11), compared to the PKBa (15 hydrogen bonds), DAPP1 (15 hydrogen bonds), Grp1 (16 hydrogen bonds) and Btk (16 hydrogen bonds) PH domain-Ins(1,3,4,5)P 4 complexes ( Figure 2 ). A major difference between the PH domainIns(1,3,4,5)P 4 complexes is the position of VL1 ( Figure 2D ). In the structures of the DAPP1/GRP1/Btk PH domains, VL1 envelopes the D5-phosphate group, which in the case of DAPP1 forms four backbone hydrogen bonds with VL1. In the case of the PDK1 PH domain, the D5-phosphate forms only a single hydrogen bond to Lys467, the residue preceding VL1, and no further direct interactions between VL1 and the inositol headgroup are observed ( Figure 2A ). In the case of PKBa, due to different orientation of Ins(1,3,4,5)P 4 , VL1 interacts with the D1-phosphate, leaving the D5-phosphate solvent exposed ( Figure 2C ). For DAPP1/GRP1/Btk and PKBa, backbone hydrogen bonds between the D2-hydroxyl groups are observed. In the case of PDK1, there is no direct interaction of the D2-hydroxyl group with the protein; instead, we observe it binding to the protein via an ordered water molecule. Strikingly, in the PDK1 Ins(1,3,4,5)P 4 -binding pocket, a layer of five-ordered water molecules (B factors 10.7-23.4 Å 2 ) separate Ins(1,3,4,5)P 4 from the protein.
The water molecules mediate a number of hydrogen bonds from Ins(1,3,4,5)P 4 to protein side chains and backbone ( Figure 2A) . One of the water molecules is consistently found in the other PH domain-Ins(1,3,4,5)P 4 complexes, in a similar position and contacting the D3-phosphate (coloured yellow, Figure 2 ). The presence of the four additional ordered water molecules is surprising, as this would appear to be entropically unfavourable. Overall, the PDK1 PH domain phosphoinositide pocket is significantly more spacious than Values between brackets are for the highest resolution shell. All measured data were included in structure refinement. that of other Ins(1,3,4,5)P 4 -binding PH domains. Perhaps, this more spacious binding pocket explains the observed ability of the PDK1 PH domain to bind different stereoisomers of phosphoinositides .
Interactions of the PDK1 PH domain with diC4-PtdIns(3,4,5)P 3
It is possible that some of the water molecules close to the D1-phosphate are replaced by the glycerol backbone upon PtdIns(3,4,5)P 3 binding. To investigate this, the PDK1 PH domain was co-crystallised with a PtdIns(3,4,5)P 3 analogue, containing two C4 acyl chains (diC4-PtdIns(3,4,5)P 3 ).
Crystals were obtained under similar conditions as for the Ins(1,3,4,5)P 4 complex, and were of the same space group with similar unit cell dimensions (Table I ). After refinement of the protein model, well defined |F o |-|F c | density was visible for the inositol ring, the phosphates and the glycerol backbone ( Figure 3A ). A partial model for diC4-PtdIns(3,4,5)P 3 was then included in the refinement (Table I) . Analysis of the resulting model shows that while Arg472 coordinates the free oxygen atoms on the D1-phosphate, the oxygen atom involved in the ester bond to the glycerol does not make any significant contact with the protein.
Of the lipid moiety, only the glycerol backbone is ordered in the crystal structure ( Figure 3A ). The glycerol backbone projects away from the surface of the protein and does not display any other interactions. Currently, the only other example of a protein domain in complex with an ordered phosphoinositide is the PtdIns(3)Pbinding phox homology (PX) domain of the p40 phox subunit of NADPH oxidase (pdb-id 1h6h; Bravo et al, 2001 ). In Figure 3 , the structures of the PDK1 PH domain-diC4-PtdIns(3,4,5)P 3 and the PX domain-diC4-PtdIns(3)P complexes are compared after superposition on the inositol ring. Despite possessing completely different folds, the binding arrangements by which these proteins interact with the D1-phosphodiester are strikingly similar. The two oxygen atoms not involved in the two phosphoester linkages will carry most of the À1e negative charge, and it is these oxygen atoms that interact with basic residues in the underlying binding pocket on the surface of the proteins. In the PDK1 PH domain, the guanidinium group of Arg472 hydrogen bonds both these oxygen atoms, while in the PX domain each oxygen atom interacts separately with a basic residue (Arg60/Lys92). Consequently, the oxygen atom involved in the phosphoester bond to the glycerol projects away from the binding pocket and in neither structure interacts with the protein. However, in contrast to the PDK1 PH domain diC4-PtdIns(3,4,5)P 3 complex, the glycerol backbone in the PX domain-diC4-PtdIns(3)P complex displays hydrophobic interactions with an exposed tyrosine side chain (Tyr94), which is not observed in the PDK1 PtdIns(3,4,5)P 3 complex (compare Figure 3A and B).
To investigate whether the PDK1 PH domain undergoes ligand-induced conformational change when it binds PtdIns(3,4,5)P 3 , the PDK1 PH domain structure was solved in the absence of any ligand (Table I) . However, all four independent molecules in the asymmetric unit show one molecule of sulphate, presumably originating from the 0.2 M ammonium sulphate containing crystallisation buffer, at the position equivalent to the D3-phosphate in the Ins(1,3,4,5)P 4 structure (Supplementary Figure 1) . Crystal structures of other noncomplexed PH domains, including Grp1 and PKBa (Milburn et al, 2003) , also contain a phosphate/sulphate at equivalent positions. The uncomplexed structures of PDK1 superimpose well onto the Ins(1,3,4,5)P 4 and PtdIns(3,4,5)P 3 complexes (pairwise with an average RMSD of up to 0.6 Å , Supplementary  Figure 1) . No significant conformational changes are visible even in the VLs that are involved in ligand binding, with the exception of Lys467, which occupies the position of the inositol ring in the absence of ligand but rotates to a position to contact the D5-phosphate upon ligand binding. This suggests that the PDK1 PH domain, like most other PH domains analysed to date, assumes the same conformation in the presence or absence of phosphoinositides. In contrast, there is evidence that the PKBa PH domain undergoes a conformational change when it binds to PtdIns(3,4,5)P 3 (Mora et al, 2004) , which is thought to enhance the rate at which PKB can be activated by PDK1 (Vanhaesebroeck and Alessi, 2000) . Figure 4A shows a summary of the ligand-protein hydrogen bonds between PtdIns(3,4,5)P 3 and residues of the PDK1 PH domain. To determine the contribution of the interactions to the affinity for phosphoinositides, these residues were mutated in full-length PDK1 and expressed as GST-fusion proteins in HEK-293 cells. The ability of these mutants to bind PtdIns(3,4,5)P 3 , PtdIns(3,4)P 2 and PtdIns(4,5)P 2 was first tested with a qualitative protein-phospholipid overlay assay (Dowler et al, 2002 ) ( Figure 4B ). As reported previously, Figure 4B ). The individual mutation of Arg472, Tyr486, Lys 495 or Arg521 had little or moderate effects on phosphoinositide binding. Of particular interest was the effect of mutation of Lys467 on the ability of PDK1 to bind D5-phosphorylated phosphoinositides, as Lys467 is the only residue to contact the D5-phosphate (Figures 2 and 4) . In order to assess accurately the contribution of Lys467 to ligand binding, we employed a novel time-resolved fluorescence resonance energy transfer (TR-FRET) assay described in Materials and methods, which quantitatively measures binding of PDK1 to phosphoinositides ( Figure 5 ). In agreement with previous surface plasmon resonance (SPR) studies (Currie et al, 1999) , in the TR-FRET assays, PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 were found to bind PDK1 with significantly higher affinity than PtdIns(4,5)P 2 ( Figure 5 ). Affinities obtained are in close agreement for TR-FRET and SPR for both PtdIns(3,4,5)P 3 (4.0 and 1.6 nM), and PtdIns(3,4)P 2 (23 and 5.2 nM), respectively. In contrast, for PtdIns(4,5)P 2 , a lower affinity of 700 nM was measured by TR-FRET compared to 24 nM that was calculated from previous SPR studies (Currie et al, 1999) . We next used the TR-FRET assay to investigate how mutation of Lys467 affected binding to PtdIns(4,5)P 2 . Mutation of Lys467 to Ala resulted in an Beight-fold reduction in affinity for PtdIns(4,5)P 2 , whereas the more conservative replacement of Lys467 to Arg maintained high-affinity PtdIns(4,5)P 2 binding. Interestingly, in agreement with the structural data, the PDK1[K467A] mutant interacted with six-to eight-fold lower affinity to all D5-phosphorylated inositides including PtdIns(3,4,5)P 3 ( Figure 5 ). In comparison, affinities for PtdIns(3,4)P 2 were reduced by two-fold.
Mutations of the lipid-binding site: functional analysis
Binding of PDK1 to inositol phosphates
The structures of the PDK1 PH domain show that the phosphoinositide-binding site of PDK1 is unusually spacious, and, in contrast to other PtdIns(3,4,5)P 3 -binding PH domains, additional space is present around the D2-and D6-hydroxyl groups, which potentially could accommodate further phosphate groups (Figure 3) . Physiologically, only inositol phosphates but not phosphoinositides are known to be phosphorylated at the D2 and/or D6 position (Michell, 1997; Irvine and Schell, 2001) . Ins (1, 3, 4, 5, 6 )P 5 and InsP 6 are present at high micromolar levels within the cell, at higher levels than Ins(1,3,4,5)P 4 or Ins(1,4,5)P 3 (Orchiston et al, 2004) . These observations prompted us to analyse the binding of inositol phosphates to full-length PDK1 employing the TR-FRET assay, which can be used for this purpose.
Interestingly, Ins(1,3,4,5,6)P 5 and InsP 6 , as well as Ins(1,3,4,5)P 4 , were found to bind PDK1 with high affinity, with K i values of 20-60 nM ( Figure 6A ). In contrast, Ins(1,4,5)P 3 binding to PDK1 could not be detected. The hydrogen bonds to the D1-phosphate (Figures 2-4 ) appear to play a crucial role in mediating binding of inositol phosphates to PDK1, as Ins(3,4,5,6)P 4 had a five-fold lower affinity compared to Ins (1, 3, 4, 5, 6 )P 5 ( Figure 6A ). This is also consistent with our notion of Arg472 interacting with the delocalised negative charge on the D1-phosphate (Figure 3 ). Irvine and colleagues have suggested that binding studies using InsP 6 should be performed in the presence of Mg 2 þ as the counter ion as the physiological form of InsP 6 is complexed to Mg 2 þ (RF Irvine, unpublished observation).
Binding of inositol lipids and inositol phosphates to PDK1 was not affected by the inclusion of 1 mM Mg 2 þ (data not shown).
Evidence for physiological interaction of PDK1 with D6-phosphorylated inositol phosphates
Initially, we attempted to design a mutant of PDK1 that inhibited binding of D6-phosphorylated inositol phosphates without affecting binding of phosphoinositides. Unfortunately, all the point mutants of PDK1 that we generated, which reduced binding of InsP 6 , also affected binding to PtdIns(3,4,5)P 3 and PtdIns(4,5)P 2 . We also attempted to cocrystallise the PDK1 PH domain with Ins (1, 3, 4, 5, 6 )P 5 or InsP 6 , without success. This prompted us to compare the affinities of the isolated PH domain and full-length PDK1 for phosphoinositides and D6-phosphorylated inositol phosphates. The ability of the indicated wild type and mutant forms of PDK1 to interact with phosphoinositides was analysed using a proteinlipid overlay assay. Serial dilutions of the indicated phosphoinositides (250, 100, 50, 25, 12.5, 6 .3, 3.1 and 1.6 pmol) were spotted onto nitrocellulose membranes, which were then incubated with the purified GST-PDK1 species. The membranes were washed, and the GST-PDK1 bound to the membrane by virtue of their interaction with lipid was detected using a GST antibody (Dowler et al, 2002 
PtdIns ( (Cheng and Prusoff, 1973) . The K D value for bPIP3 for the wild type and indicated mutant of PDK1 is also stated. Surprisingly, we observed that the isolated PH domain of PDK1, although it still interacted with PtdIns(3,4,5)P 3 and PtdIns(4,5)P 2 with high affinity, possessed 40-fold reduced affinity for InsP 6 and five-fold lower affinity for Ins (1,3,4 ,5,6)P 5 ( Figure 6A) . Inspection of the structure of the PH domain-Ins(1,3,4,5)P 4 complex suggests that a Figure 6 Interaction of PDK1 with inositol phosphates. (A) Affinities of wild-type PDK1 and its isolated PH domain (residues 409-556), for the indicated phosphoinositides and inositol phosphates were measured by the TR-FRET assay using the approach described in Figure 5A and B. The K D value for biotinylated-PtdIns(3,4,5)P 3 (bPIP3) is also stated. (B) HEK-293 cells were transiently transfected with DNA constructs encoding the GFP-tagged PKBa PH domain (residues 1-123, panels 1-3), wild-type PDK1 (panels 4-6), the isolated PDK1 PH domain (residues 409-556, panels 7-9) and the non-PtdIns(3,4,5)P3-binding isolated PDK1[K465E] PH domain (residues 409-556, panels 10-12). At 10 h posttransfection, the cells were serum starved for 16 h and either left unstimulated, stimulated with IGF1 for 10 min, or treated with 100 nM wortmannin for 20 min and then stimulated with IGF1 for 10 min. The cells were then fixed and imaged using a Zeiss LSM 510 META confocal microscope with an optical section thickness of 0.5 mm. The cells shown are representative images obtained in three separate experiments. (C) Wild-type GST PKBa was incubated with PDK1, magnesium, g[ 32 P]ATP in the presence ( þ ) or absence of 100 mM phosphatidylserine (PS), 100 mM phosphatidylcholine (PC) vesicles containing 10 mM PtdIns(3,4,5)P 3 and/or 300 mM of the indicated inositol phosphates, and the activation of PKBa was assessed as described previously (Alessi et al, 1997) . In samples in which PtdIns(3,4,5)P 3 was omitted, the PC/PS vesicles were still added. Phosphorylation of the PKB was determined following electrophoresis on a 4-12% gradient polyacrylamide gel, either by immunoblotting with the phosphospecific Thr308 antibody or by autoradiography of the Coomassie Blue-stained PKBa band. PDK1 activity was assayed as above, employing the PDKtide peptide substrate rather than by measuring PKB activation and phosphorylation. Experiments were performed in quadruplicate and similar results obtained in two to four separate experiments. D6-phosphate would be solvent exposed and unable to interact with the PH domain. However, in the context of the fulllength PDK1, the D6-phosphate may well form interactions with non-PH domain regions of the protein, explaining the observed higher affinity of full-length PDK1 for D6-phosphorylated inositol phosphates. Clearly, further structural studies are required to investigate this specific interaction and to understand the alignment of the PH domain and the kinase domain in context of the full-length PDK1 protein.
We next studied the cellular location of green fluorescent protein (GFP)-tagged full-length PDK1 compared to the isolated PH domain of PDK1. As observed previously (Currie et al, 1999) , full-length PDK1 was mainly cytosolic, with only a small fraction being at the membrane, and was excluded from the nucleus in unstimulated HEK-293 cells. PDK1 did not markedly translocate to the plasma membrane following stimulation of cells with the PI 3-kinase agonist IGF1. Similarly, localisation of full-length PDK1 was not affected by the PI 3-kinase inhibitor wortmannin ( Figure 6B , panels 4-6). In parallel experiments, we observed IGF1-induced plasma membrane translocation of the PtdIns(3,4,5)P 3 -binding PH domain of PKBa, which was inhibited by wortmannin ( Figure 6B , panels 1-3). The isolated PDK1 PH domain was localised in the cytoplasm and nucleus of unstimulated cells, and, in contrast to full-length PDK1, IGF1 induced a marked translocation to the plasma membrane that was inhibited by wortmannin ( Figure 6B , panels 7-9). A non-phosphoinositide-binding isolated PDK1[K465E] PH domain mutant was localised throughout the cell and did not translocate to the plasma membrane upon IGF1 stimulation ( Figure 6B , panels 10-12). Control Western blotting demonstrated the absence of proteolytic degradation of the expressed constructs (data not shown). Taken together, these findings are consistent with a model in which full-length PDK1 is anchored in the cytosol through high-affinity binding to D6-phosphorylated inositol phosphates. Similar observations have been made in Dictyostelium discoideum, in which Luo et al (2003) followed the localisation of the PH domain of Crac (PH Crac ). Crac shows high affinity for diphosphoinositol pentakisphosphate (PP-InsP 5 , the isomer was not stated), and appears mostly cytosolic, as is PDK1 in our study. Following cAMP stimulation, which causes PtdIns(3,4,5)P 3 accumulation in D. discoideum, the movement of PH Crac is potentiated in mutants lacking inositol hexakisphosphate kinase, the enzyme responsible for PP-InsP 5 synthesis. It should be noted that levels of inositol diphosphates in D. discoideum are about 100 times those of mammalian tissues, but still only about half those of InsP 6 (Luo et al, 2003) . PDK1 was found to interact with 5PP-InsP 5 , with a significantly lower affinity (K i 400 nM) than Ins (1, 3, 4, 5, 6 )P 5 and InsP 6 ( Figure 6A ). As the cellular concentration of 5PP-InsP 5 is much lower than Ins (1, 3, 4, 5, 6 )P 5 and InsP 6 , it is unlikely that 5PP-InsP 5 is a physiological ligand for PDK1.
The PKBa PH domain shows rapid translocation to the plasma membrane ( Figure 6B , panels 1-3) upon IGF1 stimulation. PKBa PH domain and PDK1 show similar affinities for phosphoinositides, but PKBa PH domain shows significantly lower affinity towards higher inositol phosphates (Frech et al, 1997) . Indeed, InsP 6 binds PDK1 with 80-fold higher affinity than PKBa PH domain. As such, the competition between cytosol-localised inositol phosphates and membrane-localised phosphoinositides greatly favours phosphoinositide binding in the case of the PKBa PH domain, resulting in a marked translocation of PKBa PH domain to the plasma membrane in IGF1 treated cells ( Figure 6B, panels 1-3) . Consistent with the notion that high-affinity binding to inositol phosphates maintains PDK1 located in the cytoplasm, the isolated PH domain of PDK1, which displays high-affinity interactions with phosphoinositides, but has an affinity (4.1 mM) similar to that of PKBa for InsP 6 (8.7 mM, (Frech et al, 1997) ), is seen to translocate in a fashion analogous to the PKBa PH domain. Our data do not rule out the possibility that other ligands/factors could interact with full-length PDK1, contributing towards its cytosolic or membrane localisation. In this regard, it has recently been reported that PDK1 can be stabilised at the cell membrane by interaction with Grb14, which binds the insulin receptor through an SH2 domain (King and Newton, 2004) .
In many studies of PH domain-containing proteins, the lipid-binding and localisation properties of the PH domain are assessed employing the isolated PH domain rather than the full-length protein (Irvine, 2004) . Our data emphasise a pitfall of this approach, as the isolated PH domain of PDK1 has quite distinct inositol phosphate-binding properties and localisation pattern, compared to the full-length protein. Recently, it was shown that the isolated PH domain of phospholipase Cd4 (PLCd4) was localised at the plasma membrane, whereas the full-length protein localises at intracellular membranes, and also showed differences in PtdIns(4,5)P 2 versus Ins(1,4,5)P 3 binding (Lee et al, 2004) . Thus, in order to determine the key localisation signals of lipid-binding proteins, we would recommend comparing the lipid-binding and localisation properties of the isolated lipid-binding domain with that of the full-length protein.
We next investigated whether Ins (1, 3, 4, 5, 6 )P 5 and InsP 6 could compete with PtdIns(3,4,5)P 3 in regulating the activation of PKB by PDK1 in an in vitro assay. Addition of 300 mM InsP 6 or Ins (1, 3, 4, 5, 6 )P 5 inhibited the activation and phosphorylation of PKB in the presence of PtdIns(3,4,5)P 3 , by over 80% ( Figure 6C ). InsP 6 or Ins (1, 3, 4, 5, 6 )P 5 did not directly inhibit PDK1 catalytic activity, as the phosphorylation of the PDKtide peptide substrate by PDK1 was not affected by D6-phosphorylated inositol phosphates ( Figure 6C ). It has also been reported that increasing extracellular Ins (1, 3, 4, 5, 6 )P 5 in cells lowered PKB activation, through an undefined mechanism (Piccolo et al, 2004) . The data presented here indicate that these effects could be mediated, at least in part, through binding of PDK1 to Ins (1, 3, 4, 5, 6 )P 5 and anchoring it in the cytosol. It is also possible that Ins (1, 3, 4, 5, 6 )P 5 might bind to the PH domain of PKB in vivo, and thus affect its translocation to the plasma membrane.
Several other PtdIns(3,4,5)P 3 -binding PH domains including Grp1 and Btk have been shown to interact in vitro with InsP 6 and Ins (1, 3, 4, 5, 6 )P 5 . Btk interacts with both InsP 6 and Ins (1, 3, 4, 5, 6 )P 5 with K i of 90 nM (Kojima et al, 1997) , whereas Grp1 binds to InsP 6 and Ins (1, 3, 4, 5, 6 )P 5 with K D 's of 6 and 0.3 mM, respectively (Kavran et al, 1998) . PtdIns(3,4,5)P 3 recruits Grp1 and Btk to the plasma membrane, where they are thought to exert their physiological effects. Thus, if it occurred in vivo, inositol phosphate binding to these PH domain-containing proteins would inhibit their function. In the case of PDK1, cytosolic localisation is important in enabling PDK1 to activate substrates that do not bind lipids, such as SGK or S6K. Our data indicate that the micromolar levels of Ins (1, 3, 4, 5, 6 )P 5 and InsP 6 found in cells would be sufficient to act as physiological ligands of PDK1, and could compete with PtdIns(3,4,5)P 3 , PtdIns(3,4)P 2 and PtdIns(4,5)P 2 for binding to PDK1. Such a mechanism could ensure that sufficient PDK1 was distributed in both the cytosol and plasma membrane to enable PDK1 to fulfil its cellular functions. Thus, where the binding of Btk and Grp1 to inositol phosphates would act as a brake in signalling, for PDK1 this binding would accelerate activation of cytoplasmic substrates. In this respect, PDK1 is unique among PH domain-containing proteins described so far.
Conclusions
Here we describe the unusual structure of the PDK1 PH domain. It possesses several unique features not previously observed in other PH domains, including the N-terminal bud which forms an integral part of the overall PH domain structure. The PDK1 PH domain in complex with a PtdIns(3,4,5)P 3 analogue shows a surprising analogy in the phosphoinositide-binding mode of the PDK1 PH domain and the PX domain of p40 phox . We define the relative importance of the residues in the ligand-binding site for enabling PDK1 to bind phosphoinositides. In particular, we identify Lys467 as the residue in PDK1 responsible for binding the D5-phosphorylated ligands and thus permitting interaction with PtdIns(4,5)P 2 . Moreover, the PDK1 PH domain possesses a much more spacious ligand-binding site, which we demonstrate enables PDK1 to interact with Ins (1, 3, 4, 5, 6 )P 5 and InsP 6 with high affinity. We perform studies that support the notion that these ligands could function to anchor PDK1 in the cytosol, where it is needed to activate its nonlipidbinding substrates. Overall, our results provide a molecular explanation for how PDK1 could be localised both at the membrane and the cytosol of cells.
Materials and methods
Protein expression, purification, crystallisation and data collection PDK1 PH domain (residues 409-556) was expressed in Escherichia coli, purified and crystallised as described previously . Further details on crystallisation conditions, data collection, as well as structure determination and analysis can be found in the Supplementary data. The refinement statistics can be found in Table I .
Analysis of PDK1 phosphoinositide and inositol phosphate interactions
For qualitative protein lipid overlay assays, wild type and mutants of full-length PDK1 were expressed as GST fusion proteins (pEBG vector) in human embryonic kidney HEK-293 cells, as described previously (Alessi et al, 1997) . The phospholipid overlay assays were performed as described previously (Dowler et al, 2002) , using di-palmitoyl-phosphoinositides from Cell Signals Inc. (Columbus, USA). The quantitative TR-FRET analysis of binding was performed as described by Gray et al (2003) . To determine K D values for biotinylated diC8-PtdIns(3,4,5)P 3 , increasing amounts (0-500 nM) of biotinylated diC8-PtdIns(3,4,5)P 3 were incubated with GSTtagged wild type and mutant full-length PDK1 or wild-type PH domain of PDK1 (20 nM) in the presence of excess europiumlabeled goat anti-GST antibody and streptavidin-conjugated allophycocyanin (APC). The binding of the biotinylated lipid to the protein allows FRET to occur between europium (donor) and APC (acceptor). Fluorescence is monitored at 665 and 505 nm; the ratio of these signals allows determination of relative amount of binding. Saturation-binding isotherms are presented in Figure 5A . Competition assays were performed with a fixed amount (80 nM) of biotinylated lipid and increasing amounts of competing agent (diC8 phosphoinositides or inositol phosphates). IC 50 values were determined, from which K i values were calculated, according to the equation below (Cheng and Prusoff, 1973) . All curve fitting was performed using Prism (GraphPad).
Localisation studies
Cells were fixed in 4% (w/v) paraformaldehyde in PHEM buffer (60 mM Pipes, 25 mM Hepes, 10 mM EGTA and 2 mM MgSO 4 , pH 7.0). The cells were washed three times with PBS and mounted on slides with Hydromount. The cells were imaged to monitor GFP fluorescence and confocal sections collected, using a Zeiss LSM 510 META confocal microscope.
A detailed description of all other methods employed in this study can be found in the supplementary data of this paper.
Supplementary data
Supplementary data are available at The EMBO Journal Online.
